Mary Anne Heino
President and Chief Executive Officer
Mary Anne Heino brings to Lantheus more than 25 years of diverse pharmaceutical industry experience. Joining Lantheus in April 2013 as Chief Commercial Officer, Ms. Heino was promoted to Chief Operating Officer in March 2015 and to President and Chief Executive Officer in August 2015. Prior to joining Lantheus, Ms. Heino led Angelini Labopharm LLC and Labopharm USA in the roles of President and Senior Vice President of World Wide Sales and Marketing. Before that, Ms. Heino served in numerous capacities at Centocor, Inc., a Johnson & Johnson Company, including Vice President Strategic Planning and Competitive Intelligence, Vice President Sales, Executive Director Customer Relationship Management and Senior Director Immunology Marketing. Ms. Heino began her professional career with Janssen Pharmaceutica as a Sales Representative in June 1989 and worked her way up to the role of Field Sales Director in 1999. Ms. Heino received her Master’s in Business Administration from the Stern School of Business at New York University. She earned a Bachelor’s of Science in Nursing from the City University of New York and a Bachelor’s of Science in Biology from the State University of New York at Stony Brook.
Chief Financial Officer
Jack Crowley serves as the Company’s Chief Financial Officer. He brings to the role more than 28 years of financial management and accounting experience. He previously served as interim Chief Financial Officer from December 2015 until March 2016. Prior to that, he held the roles of Vice President, Chief Accounting Officer from March 2015 to December 2015, Vice President, Finance from April 2013 until March 2015, and was Director, Accounting from September 2010 until April 2013.
Prior to joining Lantheus, Mr. Crowley served in the roles of Assistant Corporate Controller, and prior to that, Director of Finance at Biogen Idec. Mr. Crowley also previously served as Director of Accounting at Fisher Scientific International. Prior to Fisher, Mr. Crowley was a Senior Audit Manager in the Technology practice of PriceWaterhouseCoopers. Mr. Crowley holds a Master of Business Administration from the University of Massachusetts and a Bachelor of Science in Business Administration from Westfield State University, and is a Certified Public Accountant.
Vice President, Manufacturing and Operations
William (Bill) Dawes was appointed Vice President, Manufacturing and Supply Chain of Lantheus Medical Imaging in 2008. He brings nearly 15 years of manufacturing expertise to his position, most recently serving as General Manager, Medical Imaging Technical Operations for Bristol-Myers Squibb Medical Imaging. Bill began his career with DuPont Merck Pharmaceuticals where he built a strong operations background through positions of increasing responsibility in the areas of packaging, manufacturing and project engineering. Bill received a Bachelor’s degree in engineering from Hofstra University.
General Counsel and Senior Vice President, Strategy and Business Development
Michael (Mike) Duffy joined Lantheus as Vice President, General Counsel and Secretary in 2008. Prior to joining Lantheus, he served as Senior Vice President, General Counsel and Secretary of Point Therapeutics, Inc., a Boston-based biopharmaceutical company. He has also served as General Counsel and in other leadership positions for several technology companies in the Boston area and in Washington, D.C. Mike began his legal career with Ropes & Gray in Boston and holds law degrees from the University of Pennsylvania and Oxford University and an undergraduate degree from Harvard College.
Senior Vice President, Commercial
Tim Healey joined Lantheus as Senior Vice President, Commercial in November 2015. In his role, Tim oversees global sales, marketing, distributor and international operations for the company. He brings 28 years of leadership experience in global product marketing, strategic planning, innovation, market access and reimbursement, government affairs, and business development. He most recently served as President of TGH Healthcare Consulting, LLC, an independent consulting practice serving pharmaceutical, life sciences and health services companies. Prior to that, Tim spent nearly three years with Abbott Laboratories and then AbbVie, Inc., a spinoff of Abbott, as Vice President, U.S. Virology. Before joining Abbott/AbbVie, Tim served as Senior Vice President, Commercial Operations at AMAG Pharmaceuticals and Executive Director, CNS Marketing at Sepracor. Earlier in his career, Tim held positions at Aventis, Hoechst Marion Roussel, Marion Merrell Dow, and Marion Laboratories, Inc., including sales and sales management roles. He received a Bachelor of Science from Boston College and an MBA from Babson College, Franklin W. Olin Graduate School of Business.
Cesare Orlandi, MD
Chief Medical Officer
Dr. Cesare (Ces) Orlandi joined Lantheus in March 2013 as Chief Medical Officer. Ces brings to the company more than 20 years of diverse pharmaceutical industry experience with a proven track record of directing successful drug development programs, providing leadership in product pipeline portfolio management and overseeing interactions with regulatory agencies. Ces most recently served as Senior Vice President and Chief Medical Officer of TransTech Pharma, Inc., a clinical-stage pharmaceutical company, where he led drug development from Phase 1 through Phase 3 trials for the company’s pipeline programs. Prior to joining TransTech, Ces served as the Senior Vice President and Chief Medical Officer of Cardiokine, Inc., a specialty pharmaceutical company, completing the late stage development of lixivaptan, a Phase 3 program in 20 countries and over 500 sites worldwide. Earlier in his career, he worked with Otsuka Pharmaceuticals, Medco Research Inc. and the Radiopharmaceutical Division of Du Pont Merck Pharmaceutical Company, which is now Lantheus Medical Imaging. Ces received his medical degree with honors from the University of Pavia Medical School, Pavia, Italy. He is currently an Adjunct Assistant Professor of Medicine at Tufts University School of Medicine, Boston.
Vice President, Research and Pharmaceutical Development
Simon Robinson has served as Vice President Research and Pharmaceutical Development since 2010. He has held positions of increasing responsibility with the company for imaging agent discovery for more than 10 years. Simon has more than 20 years of industrial experience in molecular targeted small molecule development with research positions at Bristol Myers Squibb, Sphinx Pharmaceuticals, BASF and Dupont Pharmaceuticals. He has a Ph.D. and B.Sc. in Pharmacology from the University of Leeds, England and did post-doctoral training at the University of Wisconsin Clinical Cancer Center.
Vice President, Quality
Carol Walker joined Lantheus in February 2015 as Vice President, Quality. She brings to the company 28 years of expertise and leadership in quality assurance, quality control and regulatory affairs in the medical device and in vitro diagnostics industries. She most recently served as Vice President of Quality Assurance and Regulatory Affairs for Intelligent Medical Devices, Inc. (IMDx), a company that designs, develops and manufactures in vitro diagnostic devices. Prior to that, Carol spent 11 years with Siemens Healthcare Diagnostics where she held positions of increasing responsibility, including Vice President of Quality Assurance. Earlier in her career, Carol held a variety of quality control positions during her 15 year tenure with Nova Biomedical, one of the 25 largest in vitro diagnostic companies in the world. Carol received a B.S. in medical technology from Rochester Institute of Technology.